Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Karen Wilde knows from her own perspective how important it is to that Myeloma Australia receives financial support and that's why she's thrilled that the racing industry will again be to the fore ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...

According to The Daily Mail, Zach Stubbings —a former flight sergeant and helicopter winchman—was diagnosed with multiple ...

Zach Stubbings was diagnosed with multiple myeloma, cancer of the blood and bone marrow, in 2013, thirteen years after ...

PRINCE William’s military flying instructor has died of cancer after years of exposure to toxic helicopter exhaust fumes.